Amylyx Pharmaceuticals, Inc. (AMLX) earnings date
Mar 2, 2027, before open estimated
Estimated from the company's SEC filing cadence. The company has not confirmed it. Companies usually announce two to four weeks ahead.
- Fiscal period
- Q4 FY2026
- Confidence
- 27% chance of landing within a day
- Source
- Filing history on EDGAR
- Last checked
- 2026-11-19
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
How this company behaves
| Announces its report date | Not enough announcements on file yet to say |
| Reports after the quarter ends | 38 days, typically, give or take 12 (last 8 releases) |
Last 8 releases
| Period | Released | Timing | Days after period end | Filing |
|---|---|---|---|---|
| Q3 FY2026 | Thu, Nov 5, 2026 | before open | 36 | 8-K |
| Q2 FY2026 | Thu, Aug 6, 2026 | before open | 37 | 8-K |
| Q1 FY2026 | Thu, May 7, 2026 | before open | 37 | 8-K |
| Q4 FY2025 | Tue, Mar 3, 2026 | before open | 62 | 8-K |
| Q3 FY2025 | Thu, Nov 6, 2025 | before open | 37 | 8-K |
| Q2 FY2025 | Thu, Aug 7, 2025 | before open | 38 | 8-K |
| Q1 FY2025 | Thu, May 8, 2025 | before open | 38 | 8-K |
| Q4 FY2024 | Tue, Mar 4, 2025 | before open | 63 | 8-K |
What they guided beta
| Q3 FY2026 | "We remain on track to submit our NDA by year-end and are executing on our comprehensive commercial readiness plans ahead of a potential launch of avexitide in 2027, if approved." exhibit |
| Q3 FY2026 | "Amylyx remains on track to submit a New Drug Application to the FDA by the end of 2026 ." exhibit |
| Q2 FY2026 | "Cash runway expected to fund operations into 2028" exhibit |
| Q2 FY2026 | "Amylyx presented data from its first-in-human, dose-ranging Phase 1 LUMINA clinical trial of AMX0114, an investigational antisense oligonucleotide (ASO) targeting calpain-2 for the potential treatment of amyotrophic lateral sclerosis (ALS), at the 2026 European Network to Cure ALS (ENCALS) Annual Meeting in June 2026." exhibit |
| Q2 FY2026 | "Based on its current operating plans, Amylyx expects a cash runway into 2028. 2" exhibit |
Get this as JSON
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/AMLX
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/AMLX
Put this date on your page
A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
HTML
<a href="https://veritasdata.dev/company/AMLX/"><img src="https://veritasdata.dev/embed/AMLX.svg" alt="AMLX earnings date" width="240" height="56"></a>
Markdown
[](https://veritasdata.dev/company/AMLX/)
Script
<script async src="https://veritasdata.dev/embed/AMLX.js"></script>
Get a free key: 100 calls, every company
Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.
curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/AMLX"
Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.